ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
67.41
-2.21 (-3.17%)
At close: Nov 6, 2026, 4:00 PM EST
67.75
+0.34 (0.50%)
After-hours: Nov 6, 2026, 7:34 PM EST

ANI Pharmaceuticals Revenue

ANI Pharmaceuticals had revenue of $290.78M in the quarter ending September 30, 2026, with 27.64% growth. This brings the company's total for the last twelve months to $1.04B, up 25.94% year-over-year. In the year 2025, ANI Pharmaceuticals had annual revenue of $883.37M with 43.78% growth. That makes ANI Pharmaceuticals the 7,465th largest company in the world by revenue and 1,777th in the United States.

Revenue (ttm)
$1.04B
Revenue Growth
+25.94%
P/S Ratio
1.37
Revenue / Employee
$1,073,549
Employees
970
Market Cap
1.43B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Rare Disease and Brands 483.93M 54.8%
  • Generics and Other 399.43M 45.2%

By Geography

Chart
  • United States 852.44M 96.5%
  • International 30.92M 3.5%
Fiscal year ended Dec 31, 2025 See the full ANI Pharmaceuticals breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025883.37M268.99M43.78%
Dec 31, 2024614.38M127.56M26.20%
Dec 31, 2023486.82M170.43M53.87%
Dec 31, 2022316.39M100.25M46.38%
Dec 31, 2021216.14M7.66M3.67%
Dec 31, 2020208.48M1.93M0.93%
Dec 31, 2019206.55M4.97M2.47%
Dec 31, 2018201.58M24.73M13.99%
Dec 31, 2017176.84M48.22M37.49%
Dec 31, 2016128.62M52.30M68.53%
Dec 31, 201576.32M20.35M36.36%
Dec 31, 201455.97M25.89M86.06%
Dec 31, 201330.08M9.71M47.67%
Dec 31, 201220.37M19.94M4,581.27%
Dec 31, 2011435.16K-2.04M-82.41%
Dec 31, 20102.47M1.22M96.67%
Dec 31, 20091.26M-2.52M-66.73%
Dec 31, 20083.78M3.29M666.82%
Dec 31, 2007493.05K-13.95M-96.59%
Dec 31, 200614.44M14.18M5,488.76%
Dec 31, 2005258.35K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.